| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $23.92B | $19.61B | $18.84B |
| YoY Revenue Growth % | +22.0% | +4.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $10.4M | $7.0M | $6.0M |
| Operating Margin % | 0.0% | 0.0% | 0.0% |
| Net Income (GAAP) | $8.9M | $5.9M | $5.1M |
| EBITDA (Normalized) | $448.8M | $503.0M | $684.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $9.31B | $2.67B | $19.59B |
| Capital Expenditures (CapEx) | $548.0M | $620.0M | $847.7M |
| Free Cash Flow (FCF) | $8.76B | $2.05B | $18.74B |
| FCF Margin % | 36.6% | 10.5% | 99.5% |
| Return on Invested Capital (ROIC %) | 0.0% | 0.0% | 0.0% |
| Cash & Short-Term Equivalents | $46.03B | $42.08B | — |
| Total Debt (Short + Long Term) | $198.71B | $194.16B | $19.91B |
| Total Stockholders' Equity | $49.42B | $48.38B | $40.85B |